Syra Health Corp (SYRA) — SEC Filings
Syra Health Corp (SYRA) — 30 SEC filings. Latest: 8-K (Dec 18, 2025). Includes 17 8-K, 6 10-Q, 2 DEF 14A.
View Syra Health Corp on SEC EDGAR
Overview
Syra Health Corp (SYRA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 18, 2025: Syra Health Corp. filed an 8-K on December 18, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also covers other events and financial statements/exhibits, with the earliest event repo
Sentiment Summary
Across 30 filings, the sentiment breakdown is: 2 bearish, 25 neutral, 3 mixed. The dominant filing sentiment for Syra Health Corp is neutral.
Filing Type Overview
Syra Health Corp (SYRA) has filed 17 8-K, 6 10-Q, 2 DEF 14A, 1 DEFA14A, 1 10-K, 1 SC 13G, 2 SC 13G/A with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (30)
Risk Profile
Risk Assessment: Of SYRA's 25 recent filings, 2 were flagged as high-risk, 16 as medium-risk, and 7 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $5,491,944 |
| Net Income | -$761,763 |
| EPS | -$0.02 |
| Debt-to-Equity | N/A |
| Cash Position | $1,976,545 |
| Operating Margin | N/A |
| Total Assets | N/A |
| Total Debt | N/A |
Key Executives
- Priya Prasad
- David L. Smith
- Jennifer L. Smith
- Dr. David E. Johnson
- Ms. Jennifer L. Johnson
- Dr. David L. Johnson
- Dr. Michael J. Smith
- Dr. David J. Smith
Industry Context
Syra Health operates within the dynamic and competitive healthcare services sector. This industry is characterized by evolving patient needs, technological advancements, and significant regulatory oversight. Companies in this space often face pressure on pricing and reimbursement, alongside the need for continuous innovation to maintain market position.
Top Tags
board-of-directors (4) · 10-Q (4) · acquisition (4) · healthcare (4) · management-change (3) · financials (3) · quarterly-report (3) · merger (3) · Syra Health Corp (3) · Healthcare Staffing (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss (9 months) | $761,763 | Decreased 76.6% from $3,254,841 in 2024 |
| Net Revenues (9 months) | $5,491,944 | Decreased 8.1% from $5,975,357 in 2024 |
| Gross Profit (9 months) | $1,896,592 | Increased 43.9% from $1,318,084 in 2024 |
| Cash and Cash Equivalents | $1,976,545 | Decreased by $418,860 from December 31, 2024 |
| Total Current Liabilities | $1,053,829 | Increased from $613,549 as of December 31, 2024 |
| Accumulated Deficit | $9,585,956 | Increased from $8,824,193 as of December 31, 2024 |
| Class A Common Stock Shares Outstanding | 11,339,169 | Increased from 8,979,204 shares at December 31, 2024 |
| Class B to Class A Conversion | 2,333,340 | Shares of Class B common stock converted to Class A common stock |
| Class B Common Stock Shares Outstanding | 600,000 | As of September 17, 2025, each with 16.5 votes. |
| Votes per Class B Share | 16.5 | Significantly higher voting power compared to Class A shares. |
| Directors to be Elected | 5 | Number of members to be elected to the Board of Directors. |
| Annual Meeting Date | November 14, 2025 | Date of the Annual Meeting of Stockholders. |
| Record Date | September 17, 2025 | Date for determining stockholders entitled to vote. |
| Shares for Quorum | 10,619,585 | Minimum shares required to conduct business at the Annual Meeting. |
| Net Loss (6 months) | $535,861 | Decreased 81% from $2,837,306 in the prior year, indicating significant improvement. |
Frequently Asked Questions
What are the latest SEC filings for Syra Health Corp (SYRA)?
Syra Health Corp has 30 recent SEC filings from Jan 2024 to Dec 2025, including 17 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SYRA filings?
Across 30 filings, the sentiment breakdown is: 2 bearish, 25 neutral, 3 mixed. The dominant sentiment is neutral.
Where can I find Syra Health Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Syra Health Corp (SYRA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Syra Health Corp?
Key financial highlights from Syra Health Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SYRA?
The investment thesis for SYRA includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Syra Health Corp?
Key executives identified across Syra Health Corp's filings include Priya Prasad, David L. Smith, Jennifer L. Smith, Dr. David E. Johnson, Ms. Jennifer L. Johnson and 3 others.
What are the main risk factors for Syra Health Corp stock?
Of SYRA's 25 assessed filings, 2 were flagged high-risk, 16 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Syra Health Corp?
Forward guidance and predictions for Syra Health Corp are extracted from SEC filings as they are enriched.